Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

Similar articles for PubMed (Select 23148289)

1.

Low bone mineral density, regardless of HIV status, in men who have sex with men.

Grijsen ML, Vrouenraets SM, Wit FW, Stolte IG, Prins M, Lips P, Reiss P, Prins JM.

J Infect Dis. 2013 Feb 1;207(3):386-91. doi: 10.1093/infdis/jis687. Epub 2012 Nov 12.

2.

Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy.

Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.

Clin Endocrinol (Oxf). 2006 Aug;65(2):191-7.

PMID:
16886959
3.

Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.

Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.

Clin Endocrinol (Oxf). 2007 Aug;67(2):270-5. Epub 2007 Jun 4.

PMID:
17547686
4.

HIV infection and bone mineral density in middle-aged women.

Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE.

Clin Infect Dis. 2006 Apr 1;42(7):1014-20. Epub 2006 Feb 24.

5.

Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART).

Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR.

Clin Endocrinol (Oxf). 2012 May;76(5):643-8. doi: 10.1111/j.1365-2265.2011.04274.x.

PMID:
22040002
6.
7.

The association of bone mineral density with HIV infection and antiretroviral treatment in women.

Anastos K, Lu D, Shi O, Mulligan K, Tien PC, Freeman R, Cohen MH, Justman J, Hessol NA.

Antivir Ther. 2007;12(7):1049-58.

PMID:
18018763
8.

Low bone mineral density in patients with well-suppressed HIV infection: association with body weight, smoking, and prior advanced HIV disease.

Kooij KW, Wit FW, Bisschop PH, Schouten J, Stolte IG, Prins M, van der Valk M, Prins JM, van Eck-Smit BL, Lips P, Reiss P; AGEhIV Cohort Study group.

J Infect Dis. 2015 Feb 15;211(4):539-48. doi: 10.1093/infdis/jiu499. Epub 2014 Sep 1.

PMID:
25180239
9.

Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.

Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A.

J Infect Dis. 2009 Dec 1;200(11):1746-54. doi: 10.1086/644785.

10.

BMD is reduced in HIV-infected men irrespective of treatment.

Amiel C, Ostertag A, Slama L, Baudoin C, N'Guyen T, Lajeunie E, Neit-Ngeilh L, Rozenbaum W, De Vernejoul MC.

J Bone Miner Res. 2004 Mar;19(3):402-9. Epub 2003 Dec 22.

PMID:
15040828
11.

Predictors of bone mineral density in human immunodeficiency virus-1 infected children.

Jacobson DL, Spiegelman D, Duggan C, Weinberg GA, Bechard L, Furuta L, Nicchitta J, Gorbach SL, Miller TL.

J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):339-46.

PMID:
16131991
12.

Risk factors for decreased bone density and effects of HIV on bone in the elderly.

Jones S, Restrepo D, Kasowitz A, Korenstein D, Wallenstein S, Schneider A, Keller MJ.

Osteoporos Int. 2008 Jul;19(7):913-8. Epub 2007 Dec 11.

PMID:
18071649
13.

Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.

Guillemi S, Harris M, Bondy GP, Ng F, Zhang W, Lima VD, Michaels CE, Belzberg A, Montaner JS.

J Clin Densitom. 2010 Oct-Dec;13(4):456-61. doi: 10.1016/j.jocd.2010.06.001. Epub 2010 Jul 21.

PMID:
20663695
14.

HIV risk, prevention, and testing behaviors among men who have sex with men--National HIV Behavioral Surveillance System, 21 U.S. cities, United States, 2008.

Finlayson TJ, Le B, Smith A, Bowles K, Cribbin M, Miles I, Oster AM, Martin T, Edwards A, Dinenno E; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2011 Oct 28;60(14):1-34.

15.
17.

Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.

Pinto Neto LF, Ragi-Eis S, Vieira NF, Soprani M, Neves MB, Ribeiro-Rodrigues R, Miranda AE.

J Clin Densitom. 2011 Oct-Dec;14(4):434-9. doi: 10.1016/j.jocd.2011.06.004.

PMID:
22051092
18.

Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.

Gafni RI, Hazra R, Reynolds JC, Maldarelli F, Tullio AN, DeCarlo E, Worrell CJ, Flaherty JF, Yale K, Kearney BP, Zeichner SL.

Pediatrics. 2006 Sep;118(3):e711-8. Epub 2006 Aug 21.

PMID:
16923923
19.

[HIV infections and heterosexual behaviors among men who have sex with men in Chongqing municipality, China].

Li CM, Jia YJ, Ding XB, Liu JB, Xiao Y.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Sep;30(9):882-6. Chinese.

PMID:
20193219
20.

Sexual partner characteristics, serodiscordant/serostatus unknown unprotected anal intercourse and disclosure among human immunodeficiency virus-infected and uninfected black men who have sex with men in New York City.

Tieu HV, Xu G, Bonner S, Spikes P, Egan JE, Goodman K, Stewart K, Koblin BA.

Sex Transm Dis. 2011 Jun;38(6):548-54. doi: 10.1097/OLQ.0b013e318203e2d7.

PMID:
21217419
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk